K071346

Substantially Equivalent

IMMULISA INTRINSIC FACTOR ANTIBODY ELISA

Applicant: Immco Diagnostics, Inc.
Product code: LIG
Advisory panel: Clinical Chemistry
Date received: 2007-05-14
Decision date: 2007-09-24
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Buffalo, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.